Dr. Hanan Goldberg reviews current evidence supporting metastasis-directed therapy for oligometastatic prostate cancer while discussing systemic therapy, PSMA PET, patient selection, and the unanswered questions that continue to shape clinical practice.
Read More
Institutional experience supports focal therapy as an option for selected men with focal prostate cancer.
Read More
Extended nodal radiotherapy improves long-term outcomes in prostate cancer recurrence beyond PET-visible disease.
Read More
Metastasis-directed therapy improves progression outcomes and delays systemic therapy in oligometastatic prostate cancer.
Read More
Dr. Abhinav Sidana examines when whole-gland ablation may be preferable to focal therapy for selected prostate cancer patients.
Read More